Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Lo he copiado y pegado porque no tiene enlace ,si alguien puedo traducirlo.
Gracias.
- Initial Statement of Beneficial Ownership (3)
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Dyckerhoff Stefan A
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/1/2012
3. Issuer Name and Ticker or Trading Symbol
THRESHOLD PHARMACEUTICALS INC [THLD]
(Last) (First) (Middle)
755 PAGE MILL ROAD, SUITE A-200
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Street)
PALO ALTO, CA
(City) (State) (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 2. Amount of Securities Beneficially Owned
(Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 3960.0000 I By Ltd Partnership (SHAI) (1)
Common Stock 10028.0000 I By Ltd Partnership (SHQP) (2)
Common Stock 3983645.0000 I By Ltd Partnership (SHV) (3)
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant (4) 8/29/2013 Common Stock 801952.0000 $1.8600 I By Ltd Partnership (SHV) (3)
Common Stock Warrant (4) 10/5/2014 Common Stock 417050.0000 $2.0500 I By Ltd Partnership (SHV) (3)
Common Stock Warrant (4) 3/16/2016 Common Stock 251955.0000 $2.4600 I By Ltd Partnership (SHV) (3)
Explanation of Responses:
( 1) Shares held by Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
( 2) Shares held by Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
( 3) Shares held by Sutter Hill Ventures, A California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, A California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
( 4) Immediate.
Remarks:
thldsad2.txt
Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Dyckerhoff Stefan A
755 PAGE MILL ROAD, SUITE A-200
PALO ALTO, CA
X
Signatures
/s/ Robert Yin, by power of attorney 11/7/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
